Markets › UAE › ADX › JULPHAR

Gulf Pharmaceutical Industries PSC

ADX:JULPHARHealth TechnologyADX:FADGIADX:FADXSI

AED 0.9610−1.84%At closeAt close · Tue 20 Oct · Market cap $302.91M · Next earnings Thu 5 Nov

AED millions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	TTM	YoY
Depreciation & amortization	98.3	104.8	132.0	141.6	135.4	58.0	47.7	−17.8%
Change in working capital	(73.2)	(53.5)	(142.4)	(88.7)	(120.5)	(56.3)	(92.2)	−63.8%
Operating cash flow	(200.1)	26.5	(11.7)	41.7	128.0	95.8	62.4	−34.9%
Capital expenditure	(16.1)	(44.4)	(65.4)	(27.0)	(53.1)	(46.0)	(49.9)	−8.5%
Dividends paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	—
Free cash flow	(216.2)	(17.9)	(75.4)	19.6	84.3	60.1	20.9	−65.2%

AED millionsUpdated Thu 14 May ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

TTM ends 2026-06-30 and uses four consecutive reported quarters.